Global Partnerships Accelerate CMO/CDMO Market Size Expansion
The pharmaceutical outsourcing industry has seen exponential growth, significantly boosting the CMO/CDMO Market Size. The market size expansion is driven by rising R&D investments, increasing pipeline complexity, and the continuous shift of pharmaceutical companies toward outsourcing to reduce overheads. Biologics and advanced therapies, such as cell and gene treatments, have further contributed to the market’s size, requiring advanced manufacturing expertise that CDMOs specialize in. North America currently holds the largest market size due to its robust pharma ecosystem, but Asia-Pacific is quickly catching up with rapid capacity expansions. The market size is also being influenced by technology adoption, such as automation and AI, which enhance production capabilities and quality control. As the industry evolves, the growing size of the CMO/CDMO sector illustrates its critical role in ensuring a steady supply of innovative therapies while shaping the global healthcare economy.